Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy The Chemours Company stock
Own The Chemours Company stock in just a few minutes.
The Chemours Company is a specialty chemicals business based in the US. The Chemours Company shares (CC) are listed on the NYSE and all prices are listed in US Dollars. The Chemours Company employs 6,500 staff and has a trailing 12-month revenue of around USD$5 billion.
How to buy shares in The Chemours Company
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for The Chemours Company. Find the stock by name or ticker symbol: CC. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until The Chemours Company reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of The Chemours Company, depending on your broker.
- Check in on your investment. Congratulations, you own a part of The Chemours Company. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
What's in this guide?
The Chemours Company share price
Use our graph to track the performance of CC stocks over time.The Chemours Company shares at a glance
Information last updated 2021-03-03.
| 52-week range | USD$6.6419 - USD$29.0774 |
|---|---|
| 50-day moving average | USD$26.4229 |
| 200-day moving average | USD$23.8776 |
| Wall St. target price | USD$29.7 |
| PE ratio | 19.0644 |
| Dividend yield | USD$1 (4.1%) |
| Earnings per share (TTM) | USD$1.32 |
Buy The Chemours Company shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy The Chemours Company stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is The Chemours Company under- or over-valued?
Valuing The Chemours Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Chemours Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Chemours Company's P/E ratio
The Chemours Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, The Chemours Company shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
The Chemours Company's PEG ratio
The Chemours Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Chemours Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Chemours Company's EBITDA
The Chemours Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$796 million.
The EBITDA is a measure of a The Chemours Company's overall financial performance and is widely used to measure a its profitability.
The Chemours Company financials
| Revenue TTM | USD$5 billion |
|---|---|
| Operating margin TTM | 9.58% |
| Gross profit TTM | USD$1.1 billion |
| Return on assets TTM | 4.15% |
| Return on equity TTM | 29.01% |
| Profit margin | 4.41% |
| Book value | $4.93 |
| Market capitalisation | USD$4.2 billion |
TTM: trailing 12 months
Shorting The Chemours Company shares
There are currently 9.1 million The Chemours Company shares held short by investors – that's known as The Chemours Company's "short interest". This figure is 7.5% down from 9.8 million last month.
There are a few different ways that this level of interest in shorting The Chemours Company shares can be evaluated.
The Chemours Company's "short interest ratio" (SIR)
The Chemours Company's "short interest ratio" (SIR) is the quantity of The Chemours Company shares currently shorted divided by the average quantity of The Chemours Company shares traded daily (recently around 1.2 million). The Chemours Company's SIR currently stands at 7.59. In other words for every 100,000 The Chemours Company shares traded daily on the market, roughly 7590 shares are currently held short.
However The Chemours Company's short interest can also be evaluated against the total number of The Chemours Company shares, or, against the total number of tradable The Chemours Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Chemours Company's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 The Chemours Company shares in existence, roughly 50 shares are currently held short) or 0.0648% of the tradable shares (for every 100,000 tradable The Chemours Company shares, roughly 65 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The Chemours Company.
Find out more about how you can short The Chemours Company stock.
The Chemours Company share dividends
Dividend payout ratio: 50.51% of net profits
Recently The Chemours Company has paid out, on average, around 50.51% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Chemours Company shareholders could enjoy a 4.1% return on their shares, in the form of dividend payments. In The Chemours Company's case, that would currently equate to about $1 per share.
The Chemours Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The Chemours Company's most recent dividend payout was on 15 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 February 2021 (the "ex-dividend date").
The Chemours Company share price volatility
Over the last 12 months, The Chemours Company's shares have ranged in value from as little as $6.6419 up to $29.0774. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Chemours Company's is 2.2252. This would suggest that The Chemours Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.
The Chemours Company overview
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Frequently asked questions
More guides on Finder
-
How to buy Toast Inc (CC.US) stock when it goes public
Everything we know about the Toast Inc IPO, plus information on how to buy in.
-
How to buy Cyxtera (CC.US) stock when it goes public
Everything we know about the Cyxtera IPO, plus information on how to buy in.
-
How to buy ATI Physical Therapy (CC.US) stock when it goes public
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
-
How to buy Sportradar (CC.US) stock when it goes public
Everything we know about the Sportradar IPO, plus information on how to buy in.
-
How to buy Longboard Pharmaceuticals Inc (LBPH) stock when it goes public
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
-
How to buy Prometheus Biosciences Inc (RXDX) stock when it goes public
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
-
How to buy Olo Inc (OLO) stock when it goes public
Everything we know about the Olo Inc IPO, plus information on how to buy in.
-
How to buy China Eco-Materials Group Co Limited (ZGHB) stock when it goes public
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
-
How to buy Gain Therapeutics Inc (GANX) stock when it goes public
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
-
How to buy Karat Packaging Inc (KRT) stock when it goes public
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
Ask an Expert